全文获取类型
收费全文 | 206篇 |
免费 | 1篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 3篇 |
妇产科学 | 5篇 |
基础医学 | 13篇 |
临床医学 | 17篇 |
内科学 | 42篇 |
皮肤病学 | 3篇 |
神经病学 | 31篇 |
特种医学 | 1篇 |
外科学 | 20篇 |
综合类 | 1篇 |
预防医学 | 41篇 |
眼科学 | 2篇 |
药学 | 13篇 |
肿瘤学 | 14篇 |
出版年
2021年 | 3篇 |
2020年 | 5篇 |
2019年 | 9篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 3篇 |
2015年 | 3篇 |
2014年 | 6篇 |
2013年 | 8篇 |
2012年 | 16篇 |
2011年 | 19篇 |
2010年 | 9篇 |
2009年 | 11篇 |
2008年 | 15篇 |
2007年 | 23篇 |
2006年 | 12篇 |
2005年 | 7篇 |
2004年 | 13篇 |
2003年 | 10篇 |
2002年 | 15篇 |
2001年 | 5篇 |
1999年 | 5篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1992年 | 1篇 |
1991年 | 1篇 |
排序方式: 共有208条查询结果,搜索用时 46 毫秒
11.
Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma 总被引:1,自引:0,他引:1
Ayude D Gacio G Páez de la Cadena M Pallas E Martínez-Zorzano VS de Carlos A Rodríguez-Berrocal FJ 《Oncology reports》2003,10(5):1345-1350
Serum SCC, CYFRA 21-1, and CEA are the common tumour markers for head and neck squamous cell carcinoma (HNSCC), although diagnostic sensitivity should be yet improved, especially at early stages. In the present study, we have reported the diagnostic value of two novel serum tumour markers in HNSCC: alpha-L-fucosidase (AFU) activity, and total sialic acid concentration adjusted by total protein concentration (TSA/TP). Using the cut-off 4.0 U/ml, AFU showed a sensitivity of 55% with specificity levels of 91%, 85% and 50% to discriminate HNSCC patients from healthy donors, drinking and smoking subjects, and patients with benign diseases, respectively. Furthermore, AFU showed the best sensitivity (71%) in the detection of patients with premalign lesions. Using the cut-off 12.0 ng/mg, TSA/TP showed the best sensitivity levels (63%) in the diagnosis of HNSCC with specificity levels of 94%, 50% and 90%, regarding healthy donors, drinking and smoking subjects, and patients with benign diseases, respectively. It was of special interest that sensitivity in the diagnosis of HNSCC at non-disseminated stages was improved when using combinations of AFU+CYFRA or TSA/TP+CYFRA, up to 86% or 71% in TNM I, 60% or 80% in TNM II, and 80% or 60% in TNM III, respectively. 相似文献
12.
13.
Nicholas M. Barbaro MD Mark Quigg MD MSc Donna K. Broshek PhD Mariann M. Ward RN NP Kathleen R. Lamborn PhD Kenneth D. Laxer MD David A. Larson PhD MD William Dillon MD Lynn Verhey PhD Paul Garcia MD Ladislau Steiner MD PhD Christine Heck MD Douglas Kondziolka MD MSc Robert Beach MD William Olivero MD Thomas C. Witt MD Vicenta Salanova MD Robert Goodman MD 《Annals of neurology》2009,65(2):167-175
14.
15.
Adelaida Zabalegui Loreto Macia Josefa Márquez Roser Ricomá Carmen Nuin Isabel Mariscal Azucena Pedraz Concepción Germán Joaquín Moncho 《Journal of nursing scholarship》2006,38(2):114-118
PURPOSE: To provide an overview of changes in nursing education in the European Union (EU) within the framework of the Bologna Declaration, signed in 1999 by the European ministers of education, and to describe specific efforts and changes in Spain. ORGANIZING CONSTRUCTS: (a) the Bologna Declaration process, its recent reforms in all disciplines including nursing, and perspectives on future developments; (b) the Tuning Project, designed and carried out by a group of European universities to meet the challenges posed by the Bologna Declaration; and (c) efforts in a group of Spanish universities to promote higher education in nursing. FINDINGS AND CONCLUSIONS: These changes promote enhanced academic recognition, professionalism in nursing education, and graduates' competencies in practice in most European countries by specifying the undergraduate nursing degree as the minimal entrance level for practice and master's and doctoral programs for further career development. 相似文献
16.
Andrés Cabrera-León Antonio Daponte-Codina Inmaculada Mateo Elena Arroyo-Borrell Xavier Bartoll María José Bravo María Felicitas Domínguez-Berjón Gemma Renart Carlos Álvarez-Dardet Marc Marí-Dell’Olmo Julia Bolívar-Muñoz Marc Saez Vicenta Escribà-Agüir Laia Palència María José López Carme Saurina Vanessa Puig Unai Martín Mariola Bernal 《Gaceta sanitaria / S.E.S.P.A.S》2019,33(5):497
17.
Iria Cabo López MD Pedro J. García Ruiz MD Silvia Vázquez Fernández del Pozo MD Vicenta Sánchez Bernardos RN 《Movement disorders》2010,25(16):2735-2739
Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practice‐based study to evaluate the evolution appearance and evolution of motor complications in 64 de novo PD patients over 5 years and in 38 PD patients over 10 years. We studied untreated patients from initial assessment at basal conditions and evaluated every 6 months thereafter with treatment (levodopa versus other drugs). The follow‐up assessments were performed with the Unified Parkinson's Disease Rating Scale (UPDRS). At each assessment, patients were monitored regarding the development of dyskinesias, motor fluctuations, freezing, loss of postural reflexes, and cognitive impairment. We observed a significant improvement in UPDRS scores during the first year, then a progressive decline, more evident after the third year. Motor complications increased after the third year, and at the end of the survey (tenth year); drug‐induced dyskinesias and motor fluctuations were experienced (71.1 and 94.7%, respectively). After the first decade, many complications arose from the non‐levodopa–responsive features of the disease (cognitive impairment was present in 52.6% and gait freezing in 71.1%). Initial medication may influence medium‐term complications but not long‐term problems. Most long‐term disabling problems of PD were related to non‐levodopa‐responsive features. © 2010 Movement Disorder Society. 相似文献
18.
Reganon E Vila V Martínez-Sales V Vayá A Mira Y Ferrando F Aznar J 《Thrombosis research》2007,119(1):73-78
INTRODUCTION: Deep vein thrombosis (DVT) induces a systemic chronic inflammation and it has been associated with atherosclerosis. Increased levels of total sialic acid (TSA) have been shown to correlate with inflammation and atherosclerotic processes. The aim of this study was to investigate whether or not increased levels of TSA are associated with a history of DVT and with inflammation and coagulation markers, as well as with the lipid profile. MATERIALS AND METHODS: TSA, fibrinogen, C-reactive protein (CRP), fibrin D-dimer (D-dimer), prothrombin fragment 1+2 (F1+2), endogenous thrombin generation, cholesterol and triglycerides were measured in 68 patients who had suffered, in the previous 6-12 months, a first episode of idiopathic DVT, and in 68 age- and sex-matched healthy subjects. RESULTS: Levels of TSA, fibrinogen, CRP and D-dimer observed in patients were significantly higher than those detected in healthy subjects. TSA positively correlated with fibrinogen (R=0.47, p<0.01), cholesterol (R=0.46, p<0.01), triglycerides (R=0.38, p<0.01) and CRP (R=0.28, p<0.05). The logistic regression analysis confirmed that both high fibrinogen (> or =340 mg/dl) and cholesterol (> or =267 mg/dl) levels significantly and independently influence the TSA concentration. TSA levels above the 95th percentile of controls (>72 mg/dl) were detected in 33% of patients (OR=8.9; p<0.0001; 95% CI 2.4 to 31.7). CONCLUSIONS: Patients with a history of DVT had associated high levels of TSA. In these patients, TSA correlated to markers of inflammation activity and lipid profile. Thus, TSA appears to be a useful vascular inflammatory marker in idiopathic DVT. 相似文献
19.
Ruiz PJ Bernardos VS Bartolomé M Torres AG 《Journal of the neurological sciences》2007,260(1-2):283-285
Slowing of motor performance in human aging is a well demonstrated clinical observation. Age-related motor decline has been also confirmed in animal models including rodents and non human primates. We studied the motor performance of 60 normal subjects (age: 20–87). Motor study included the four timed tests (TT) recommended in CAPIT protocol: pronation–supination (PS), finger dexterity (FD), movement between two points (MTP) or tapping, and walking test (WT). Finally we compared normal controls with a group of 30 patients with Parkinson's disease (PD) of similar age. Age inversely correlated with TT performance in normal subjects (for PS, r:0.33, p < 0.01; FD, r:0.44, p < 0.0005; MTP, r:0.51, p < 0.0001; WT, r:0.59, p < 0.0001, Pearson). Our results confirm that motor performance (measured with CAPIT TT) deteriorates linearly with age. Simple tasks, such as CAPIT TT can help to study and quantify age-related motor decline. 相似文献
20.
Plaque stability largely depends on vascular smooth muscle cell (VSMC) function. VSMC secrete metalloproteinases (MMPs), matrix degrading endopeptidases, that regulate VSMC migration and function. Among them, gelatinase B or MMP-9 seems to have a protective effect by promoting a stable plaque phenotype. In macrophage foam cells oxidized LDL (oxLDL) uptake regulates MMP-9 expression. However, it is unknown whether VSMC-lipid loading by aggregated LDL (agLDL) internalization produces any effect on MMP-9 production by human resident vascular cells. In the present study, we analyzed the effect of lipid-internalization in MMP-9 and MMP-2 expression and activity and its consequences in VSMC migration. Our results show that agLDL-internalization down-regulates MMP-9 activity in a time-dependent manner up to 42% at 48h and in a dose-dependent manner up to 87% at 300 microg/mL. nLDL induced similar but not sustained decrease on MMP-9 activity. However, neither agLDL nor nLDL exerted any significant effect on MMP-2 and TIMP-1. VSMC regrowth after a scratch injury was significantly reduced by exposure to agLDL. We conclude that agLDL-lipid loading reduces MMP-9 activity and this effect is associated to inhibition of VSMC migration. Thus, agLDL internalization may have consequences on vascular remodeling after injury, and the stability of lipid-rich atherosclerotic plaques. 相似文献